Digital Marketing

Drug Discovery: Identifying and Optimizing Leads

Lead – Definition

A lead is defined as a compound, usually a small organic molecule, that demonstrates the desired biological activity in a validated molecular target.

The most important sources of clues are the “Libraries” of molecules, eg natural product libraries, peptide libraries, carbohydrate libraries, etc.

Virtual libraries can be created using “Combinatorial Chemistry”.

Lead Identification Technologies

Virtual projection.

Chemoinformatics.

Mapping of Parmacophores.

Quantitative activity structure relationship.

Virtual projection (VS):

Virtual detection is part of chemoinformatics and is used in lead identification. It involves the detection or docking of compounds based on protein structure and small molecule-based chemical similarity searching. Important features to consider when developing a VS system are: knowledge about the compounds it can test against its receptor, knowledge about receptor structure and receptor-ligand interactions in general, and standard knowledge about drugs and drug characteristics.

Chemoinformatics:

Chemoinformatics combines elements of biology and chemistry with mathematics, statistics, and computer science. Chemoinformatics analyzes focus on various types of large databases, such as macromolecular structures, three-dimensional chemical databases, and compound libraries.

Pharmacophore mapping:

Pharmacophore screening is an approach to identify lead compounds against a desired target. A pharmacophore is the specific three-dimensional arrangement of functional groups within a molecular framework that are necessary to bind to a macromolecule or the active site of an enzyme.

Quantitative Structure Activity Relationship (QSAR):

QSAR analysis refers to methods that relate the structural features of molecules to biological activity in quantitative terms. QSAR analysis attempts to establish linear relationships between selected structural features in a series of related molecules and their known level of activity.

Lead Qualities

A leader molecule must have the following desirable qualities:

(a) The potency, i.e. capable of modulating the target effectively.

(b) Solubility: It should be readily soluble in water for faster action.

(c) A milder lipophilicity: Ability to penetrate the plasma membrane.

(d) Metabolic stability: It must not be rapidly destroyed within the body.

(e) Bioavailability: faster absorption in the body.

(f) Construction of specific proteins.

(g) Less toxic or not at all toxic.

Lead Compound Optimization

Once the candidate drugs are evaluated for quality, they are registered as an investigational new drug and sent for clinical trials.

Stages of clinical trials:

preclinical phase

animal studies

Phase I

Normal (healthy) human volunteers

Stage II

Evaluation of safety and efficacy in patients, and selection of dosage regimen.

Phase III

Study of a large number of patients with placebo or comparator

Stage IV

Long-term follow-up of adverse reactions reported by pharmacists and physicians.

Summary-The scope of bioinformatics is very broad and provides an opportunity for the development of new drugs. Combinatorial chemistry approaches have made it possible to assemble large chemical libraries for testing.

Leave a Reply

Your email address will not be published. Required fields are marked *